Chennai Super KingsAnti Doping Policy
APPENDIX 4 – MONITORING PROGRAM
The following substances are placed on the 2013 Monitoring Program:
1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms per milliliter), synephrine.
2. Narcotics: In-Competition only: Hydrocodone, morphine/codeine ratio; tapentadol; tramadol.
3. Glucocorticosteroids: Out-of-Competition only
* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”
1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms per milliliter), synephrine.
2. Narcotics: In-Competition only: Hydrocodone, morphine/codeine ratio; tapentadol; tramadol.
3. Glucocorticosteroids: Out-of-Competition only
* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”